Evidence map›Paper›PMID 41138918›Full record

ArticleVirus research2025

Detection of partial deletions of the human papillomavirus 16 E6 gene in a subset of oropharyngeal and cervical cancers.

Yumiko Hashida, Shuichi Matsumoto, Nagamasa Maeda, Masanori Teshima, Masanori Daibata

Abstract read
In one paragraph

Article in Virus research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yumiko HashidaDepartment of Microbiology and Infection, Kochi Medical School, Kochi University, Nankoku, Kochi 783-8505, Japan.
Shuichi MatsumotoDepartment of Otolaryngology, Head and Neck Surgery, Kochi Medical School, Kochi University, Nankoku, Kochi 783-8505, Japan.
Nagamasa MaedaDepartment of Obstetrics and Gynecology, Kochi Medical School, Kochi University, Nankoku, Kochi 783-8505, Japan.
Masanori TeshimaDepartment of Otolaryngology, Head and Neck Surgery, Kochi Medical School, Kochi University, Nankoku, Kochi 783-8505, Japan.
Masanori DaibataDepartment of Microbiology and Infection, Kochi Medical School, Kochi University, Nankoku, Kochi 783-8505, Japan. Electronic address: daibatam@kochi-u.ac.jp.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human papillomavirus 16 (HPV16) is a major carcinogenic HPV type responsible for both cervical cancer (CC) and oropharyngeal cancer (OPC). HPV16 E6 polymorphisms vary by geographic region and are correlated with disease progression. Here, we sought to investigate HPV16 E6 variation in Japanese patients and evaluate its clinical relevance. We enrolled 379 patients with CC and OPC, and subjected 100 CC and 71 OPC samples with HPV16 DNA to E6 sequence analysis. The E6 sequence was partially deleted in 13 (13 %) CCs and 16 (23 %) OPCs. Patients with OPC harboring defective E6 had significantly worse overall survival than those with intact E6. This was observed in univariate analysis but not in multivariate analysis when adjusted for viral load. These findings indicate that low viral load is an independent prognostic factor in patients with OPC, and that E6 deletion is associated with low viral load. By contrast, prognostic differences were not observed in patients with CC. In summary, we report a newly identified gene deletion within the HPV16 E6 region associated with low viral load. These findings will facilitate further studies on the clinical and oncological significance of E6 deletion in patients with HPV16-related malignancies.

Indexed as

Gene DeletionHuman papillomavirus 16Oncogene Proteins, ViralOropharyngeal NeoplasmsPapillomavirus InfectionsRepressor ProteinsSequence DeletionUterine Cervical NeoplasmsAdultAgedAged, 80 and overDNA, ViralFemaleHumansJapanMiddle AgedDNA, ViralE6 protein, Human papillomavirus type 16Oncogene Proteins, ViralRepressor ProteinsCervical cancerGene deletionHuman papillomavirus 16Oropharyngeal cancerPrognosis

Identifiers

PMID41138918
PMCPMC12615322

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.